Ikuko Kato1, Gregory Dyson2, Michael Snyder3, Hyeong-Reh Kim4, Richard K Severson5. 1. Department of Oncology, Wayne State University School of Medicine, Detroit, USA; Department of Pathology, Wayne State University School of Medicine, Detroit, USA. 2. Department of Oncology, Wayne State University School of Medicine, Detroit, USA. 3. Department of Radiation Oncology Wayne State University School of Medicine, Detroit, USA. 4. Department of Pathology, Wayne State University School of Medicine, Detroit, USA. 5. Department of Family Medicine and Public Health Sciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
Abstract
OBJECTIVE: The objective of this study was to investigate whether cancer specific survival in rectal cancer patients is affected by patient-related factors, conditional on radiation treatment. METHODS: 359 invasive rectal cancer patients who consented and provided questionnaire data for a population-based case-control study of colorectal cancer in Metropolitan Detroit were included in this study. Their vital status was ascertained through to the population-based cancer registry. Hazard ratios (HR) for cancer specific and other deaths and 95% confidence intervals (CIs) were calculated according to selected patients' characteristics, stratified by radiation status, using joint Cox proportional hazards models. RESULTS: A total of 159 patients were found to be deceased after the median follow-up of 9.2 years, and 70% of them were considered to be cancer specific. Smoking and a history of diabetes were associated with an increased probability of deaths from other causes (HR 3.20, 95% CI 1.72-5.97 and HR 2.02, 95% CI 0.98-4.16, respectively), while regular use of non-steroidal anti-inflammatory drugs (NSAIDs) was inversely correlated with cancer-specific mortality (HR 0.50, 95% CI 0.30-0.81). Furthermore, the associations of smoking and NSAIDs with the two different types of deaths (cancer vs others) significantly varied with radiation status (P-values for the interactions= 0.014 for both). In addition, we observed a marginally significantly reduced risk of cancer specific deaths in the patients who had the relative ketogenic diet overall (HR=0.49, 95% 0.23-1.02). CONCLUSION: Further research is warranted to confirm these results in order to develop new interventions to improve outcome from radiation treatment.
OBJECTIVE: The objective of this study was to investigate whether cancer specific survival in rectal cancerpatients is affected by patient-related factors, conditional on radiation treatment. METHODS: 359 invasive rectal cancerpatients who consented and provided questionnaire data for a population-based case-control study of colorectal cancer in Metropolitan Detroit were included in this study. Their vital status was ascertained through to the population-based cancer registry. Hazard ratios (HR) for cancer specific and other deaths and 95% confidence intervals (CIs) were calculated according to selected patients' characteristics, stratified by radiation status, using joint Cox proportional hazards models. RESULTS: A total of 159 patients were found to be deceased after the median follow-up of 9.2 years, and 70% of them were considered to be cancer specific. Smoking and a history of diabetes were associated with an increased probability of deaths from other causes (HR 3.20, 95% CI 1.72-5.97 and HR 2.02, 95% CI 0.98-4.16, respectively), while regular use of non-steroidal anti-inflammatory drugs (NSAIDs) was inversely correlated with cancer-specific mortality (HR 0.50, 95% CI 0.30-0.81). Furthermore, the associations of smoking and NSAIDs with the two different types of deaths (cancer vs others) significantly varied with radiation status (P-values for the interactions= 0.014 for both). In addition, we observed a marginally significantly reduced risk of cancer specific deaths in the patients who had the relative ketogenic diet overall (HR=0.49, 95% 0.23-1.02). CONCLUSION: Further research is warranted to confirm these results in order to develop new interventions to improve outcome from radiation treatment.
Authors: Graham W Warren; Michelle A Romano; Mahesh R Kudrimoti; Marcus E Randall; Ronald C McGarry; Anurag K Singh; Vivek M Rangnekar Journal: Int J Cancer Date: 2012-04-16 Impact factor: 7.396
Authors: Xiaonan Xue; Mimi Y Kim; Mia M Gaudet; Yikyung Park; Moonseong Heo; Albert R Hollenbeck; Howard D Strickler; Marc J Gunter Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-01-04 Impact factor: 4.254
Authors: Farhat V N Din; Asta Valanciute; Vanessa P Houde; Daria Zibrova; Kevin A Green; Kei Sakamoto; Dario R Alessi; Malcolm G Dunlop Journal: Gastroenterology Date: 2012-03-06 Impact factor: 22.682
Authors: E Bastiaannet; K Sampieri; O M Dekkers; A J M de Craen; M P P van Herk-Sukel; V Lemmens; C B M van den Broek; J W Coebergh; R M C Herings; C J H van de Velde; R Fodde; G J Liefers Journal: Br J Cancer Date: 2012-03-27 Impact factor: 7.640
Authors: S Rasheed; A L Harris; P P Tekkis; H Turley; A Silver; P J McDonald; I C Talbot; R Glynne-Jones; J M A Northover; T Guenther Journal: Br J Cancer Date: 2009-05-19 Impact factor: 7.640
Authors: Daniela D Weber; Sepideh Aminzadeh-Gohari; Julia Tulipan; Luca Catalano; René G Feichtinger; Barbara Kofler Journal: Mol Metab Date: 2019-07-27 Impact factor: 7.422